These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2851303)

  • 1. In situ carcinomas of the female breast. Incidence, clinical findings and DBCG proposals for management.
    Graversen HP; Blichert-Toft M; Dyreborg U; Andersen J
    Acta Oncol; 1988; 27(6A):679-82. PubMed ID: 2851303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group.
    Ottesen GL; Graversen HP; Blichert-Toft M; Zedeler K; Andersen JA
    Am J Surg Pathol; 1993 Jan; 17(1):14-21. PubMed ID: 8383466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive breast carcinoma.
    Posner MC; Wolmark N
    Breast Cancer Res Treat; 1992; 21(3):155-64. PubMed ID: 1325215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
    Calabrese L
    Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of carcinoma in situ in normal and cancer-associated breasts.
    Alpers CE; Wellings SR
    Hum Pathol; 1985 Aug; 16(8):796-807. PubMed ID: 2991111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.
    Nielsen M; Thomsen JL; Primdahl S; Dyreborg U; Andersen JA
    Br J Cancer; 1987 Dec; 56(6):814-9. PubMed ID: 2829956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive breast cancer: Part 1. Ductal carcinoma in situ--incidence, presentation, guidelines to treatment.
    Swain SM
    Oncology (Williston Park); 1989 Mar; 3(3):25-31; discussion 40, 42, 44 passim. PubMed ID: 2561880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.
    Swain SM
    Oncology (Williston Park); 1989 Mar; 3(3):35-40; discussion 40, 42, 44 passim. PubMed ID: 2561881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.
    Blichert-Toft M; Graversen HP; Andersen J; Dyreborg U; Green A
    World J Surg; 1988 Dec; 12(6):845-51. PubMed ID: 2854930
    [No Abstract]   [Full Text] [Related]  

  • 19. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.